Le Lézard
Classified in: Health
Subject: SVY

United States and Japan Proton Therapy Market 2012-2017 & 2018-2025: Market is Set to Cross USD 10 Billion


DUBLIN, March 16, 2018 /PRNewswire/ --

The "United States and Japan Proton Therapy Market Analysis 2012 to 2017 and Forecast 2018 to 2025" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

United States and Japan Proton Therapy Market Analysis 2012 to 2017 and Forecast 2018 to 2025 presents an in-depth assessment of the proton therapy market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends.

The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for proton therapy in the United States and Japan. The research includes historic data from 2012 to 2017 and forecasts until 2025.

A comprehensive analysis has been done on market share of US proton therapy center (installed base) and treatment room by company. The report also provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies. The report further sheds light on the number of treatment rooms, current and upcoming proton therapy centers.

n addition, the report also provides essential insights on number of patients treated at US and Japan proton therapy centers. The report also includes assessment of US and Japan reimbursement scenario, proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the US and Japan proton therapy market.

The report concludes with the profiles of major players in the US and Japan proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, US proton therapy centers developed by the companies, recent development of the proton therapy market.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Hitachi, Optivus, Ion Beam Applications (IBA), Varian Medical Systems, Mevion Medical Systems, Mitsubishi Electric, Sumitomo Heavy Industries Ltd.

Key Findings:



Key Topics Covered:

1. Executive Summary

2. What is Proton Therapy?

3. Proton Therapy Current Applications

4. Proton Therapy Comparative Analysis
4.1 Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
4.2 Proton Therapy Competitive Analysis: By Company

5. Market Size & Analysis: United States & Japan Proton Therapy (2012 - 2025)
5.1 United States
5.1.1 Proton Therapy Patients Treated Statistics (Volume)
5.1.2 Proton Therapy Market Analysis (Value)
5.2 Japan
5.2.1 Proton Therapy Patients Treated Statistics (Volume)
5.2.2 Proton Therapy Market Analysis (Value)

6. Market Opportunity Assessment: United States & Japan Proton Therapy (2012 - 2025)
6.1 United States
6.1.1 Potential Proton Therapy Patient Base (Volume)
6.1.2 Potential Proton Therapy Market Demand Analysis (Value)
6.2 Japan
6.2.1 Potential Proton Therapy Patient Base (Volume)
6.2.2 Potential Proton Therapy Market Demand Analysis (Value)

7. Key Market Drivers and Inhibitors of the United States Proton Therapy Market
7.1 Market Drivers
7.2 Market Inhibitors

8. United States & Japan Number of Treatment Rooms and Forecast (2012 - 2025)
8.1 United States
8.2 Japan

9. United States & Japan Proton Therapy Center (Installed Base) and Treatment Room Market Share: By Company
9.1 United States
9.1.1 Proton Therapy Center (Installed Base) Market Share
9.1.2 Treatment Room Market Share
9.2 Japan
9.2.1 Proton Therapy Center (Installed Base) Market Share
9.2.2 Treatment Room Market Share

10. United States & Japan Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator
10.1 United States
10.1.1 Current Proton Therapy Centers
10.1.2 Demand for Proton Therapy Centers
10.2 Japan
10.2.1 Current Proton Therapy Centers
10.2.2 Demand for Proton Therapy Centers

11. United States & Japan Number of Patients Treated at Proton Therapy Centers
11.1 United States
11.2 Japan

12. United States Proton Therapy Reimbursement Scenario
12.1 United States
12.2 Japan

13. Proton Therapy Center Component Analysis
13.1 Proton Accelerator
13.2 Beam Transport System
13.3 Beam Delivery System
13.4 Nozzle
13.5 Treatment Planning System
13.6 Image Viewers
13.7 Patient Positioning System (PPS)
13.8 Human Resource

14. Proton Therapy Clinical Trail Insight by Phase, Institute & Country
14.1 Year 2017
14.2 Year 2016

15. Major Deals in Proton Therapy Market
15.1 Collaboration Deals
15.2 Licensing Agreement
15.3 Exclusive Agreement
15.4 Partnership Deals
15.5 Venture Capital Investment
15.6 Development Agreement

16. Key Companies Analysis

For more information about this report visit https://www.researchandmarkets.com/research/kzmrr2/united_states_and?w=5

Media Contact:


Research and Markets
Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



SOURCE Research and Markets


These press releases may also interest you

at 02:45
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2024....

at 02:25
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Al Shirawi Healthcare solutions, a leading distributor of medical technologies...

at 02:20
BioInvent International (STO:BINV)"During the first quarter of the year, we continued making excellent progress with our clinical pipeline targeting TNFR2 and FcyRIIB, building on the momentum we generated during a very successful 2023. Looking...

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...



News published on and distributed by: